|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 405/14 | |
| C07D 401/12 | |||
| A61K 31/4725 | |||
| A61K 31/454 | |||
| A61P 9/00 | |||
| A61P 15/00 | |||
| A61P 19/00 | |||
| A61P 27/00 |
| (11) | Number of the document | 2914590 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13786455.9 |
| Date of filing the European patent application | 2013-10-31 | |
| (97) | Date of publication of the European application | 2015-09-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/072774 |
| Date | 2013-10-31 |
| (87) | Number | WO 2014/068035 |
| Date | 2014-05-08 |
| (30) | Number | Date | Country code |
| 12190859 | 2012-10-31 | EP |
| (72) |
BOURIN, Arnaud, Pierre, Jean, BE
LEYSEN, Dirk, BE
DEFERT, Olivier, BE
BOLAND, Sandro, BE
|
| (73) |
pH Pharma Co., Ltd.,
2F., Artside Gallery 15 Jahamun-Ro 6-Gil, Jongno-Gu Seoul 03044,
KR
|
| (54) | NOVEL ROCK INHIBITORS |
| NOVEL ROCK INHIBITORS |